164 related articles for article (PubMed ID: 15033141)
21. Alzheimer's disease and Parkinson's disease.
Nussbaum RL; Ellis CE
N Engl J Med; 2003 Apr; 348(14):1356-64. PubMed ID: 12672864
[No Abstract] [Full Text] [Related]
22. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
[TBL] [Abstract][Full Text] [Related]
23. Controversy: is Parkinson's disease a single disease entity? Yes.
Takahashi H; Wakabayashi K
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
[TBL] [Abstract][Full Text] [Related]
24. Nosology of Parkinson's disease: looking for the way out of a quagmire.
Forman MS; Lee VM; Trojanowski JQ
Neuron; 2005 Aug; 47(4):479-82. PubMed ID: 16102530
[TBL] [Abstract][Full Text] [Related]
25. Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression.
Song YJ; Halliday GM; Holton JL; Lashley T; O'Sullivan SS; McCann H; Lees AJ; Ozawa T; Williams DR; Lockhart PJ; Revesz TR
J Neuropathol Exp Neurol; 2009 Oct; 68(10):1073-83. PubMed ID: 19918119
[TBL] [Abstract][Full Text] [Related]
26. Interface between tauopathies and synucleinopathies: a tale of two proteins.
Galpern WR; Lang AE
Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
[TBL] [Abstract][Full Text] [Related]
27. Alpha-synuclein: normal function and role in neurodegenerative diseases.
Norris EH; Giasson BI; Lee VM
Curr Top Dev Biol; 2004; 60():17-54. PubMed ID: 15094295
[TBL] [Abstract][Full Text] [Related]
28. The genetics of disorders with synuclein pathology and parkinsonism.
Farrer M; Gwinn-Hardy K; Hutton M; Hardy J
Hum Mol Genet; 1999; 8(10):1901-5. PubMed ID: 10469843
[TBL] [Abstract][Full Text] [Related]
29. Clinical correlates of similar pathologies in parkinsonian syndromes.
Song YJ; Huang Y; Halliday GM
Mov Disord; 2011 Feb; 26(3):499-506. PubMed ID: 21259341
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
Lee VM; Trojanowski JQ
Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
[TBL] [Abstract][Full Text] [Related]
31. Clinical overview of the synucleinopathies.
Martà MJ; Tolosa E; Campdelacreu J
Mov Disord; 2003 Sep; 18 Suppl 6():S21-7. PubMed ID: 14502652
[TBL] [Abstract][Full Text] [Related]
32. Atypical parkinsonism combining alpha-synuclein inclusions and polyglucosan body disease.
Krim E; Vital A; Macia F; Yekhlef F; Tison F
Mov Disord; 2005 Feb; 20(2):200-4. PubMed ID: 15382212
[TBL] [Abstract][Full Text] [Related]
33. Parkinsonism plus syndrome--a review.
Mitra K; Gangopadhaya PK; Das SK
Neurol India; 2003 Jun; 51(2):183-8. PubMed ID: 14570999
[TBL] [Abstract][Full Text] [Related]
34. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.
Farrer M; Kachergus J; Forno L; Lincoln S; Wang DS; Hulihan M; Maraganore D; Gwinn-Hardy K; Wszolek Z; Dickson D; Langston JW
Ann Neurol; 2004 Feb; 55(2):174-9. PubMed ID: 14755720
[TBL] [Abstract][Full Text] [Related]
35. Tuft-shaped astrocytes in Lewy body disease.
Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G
Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789
[TBL] [Abstract][Full Text] [Related]
36. How to diagnose dementia with Lewy bodies: state of the art.
Geser F; Wenning GK; Poewe W; McKeith I
Mov Disord; 2005 Aug; 20 Suppl 12():S11-20. PubMed ID: 16092075
[TBL] [Abstract][Full Text] [Related]
37. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
[TBL] [Abstract][Full Text] [Related]
38. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
Halliday GM; Macdonald V; Henderson JM
Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
[TBL] [Abstract][Full Text] [Related]
39. Atypical protein kinase C in neurodegenerative disease II: PKCiota/lambda in tauopathies and alpha-synucleinopathies.
Shao CY; Crary JF; Rao C; Sacktor TC; Mirra SS
J Neuropathol Exp Neurol; 2006 Apr; 65(4):327-35. PubMed ID: 16691114
[TBL] [Abstract][Full Text] [Related]
40. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.
Greffard S; Verny M; Bonnet AM; Beinis JY; Gallinari C; Meaume S; Piette F; Hauw JJ; Duyckaerts C
Arch Neurol; 2006 Apr; 63(4):584-8. PubMed ID: 16606773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]